About AMW Pharmaceuticals
AMW Pharmaceuticals is a company based in Warngau (Germany) founded in 2008 by Wilfried Fischer was acquired by Yunfeng Capital in July 2018. It operates as a Professional Services, and Reseller / Distribution. AMW Pharmaceuticals has raised $6.36 million across 4 funding rounds from investors including European Investment Bank, Hybio Pharmaceutical and KfW. The company has 78 employees as of December 31, 2021. AMW Pharmaceuticals offers products and services including Goserelin Implant, Leuprorelin Implant, and Drug Delivery Systems. AMW Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Warngau, Germany
- Employees 78 as on 31 Dec, 2021
- Founders Wilfried Fischer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amw Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.36 M (USD)
in 4 rounds
-
Latest Funding Round
$30.08 M (USD), Debt – Conventional
Jan 04, 2018
-
Investors
European Investment Bank
& 8 more
-
Employee Count
78
as on Dec 31, 2021
-
Acquired by
Yunfeng Capital
(Jul 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AMW Pharmaceuticals
AMW Pharmaceuticals offers a comprehensive portfolio of products and services, including Goserelin Implant, Leuprorelin Implant, and Drug Delivery Systems. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implant used for treating hormone-sensitive tumors globally.
Implant designed for hormone-sensitive tumor treatment worldwide.
Biodegradable systems developed for controlled drug release.
Unlock access to complete
Funding Insights of AMW Pharmaceuticals
AMW Pharmaceuticals has successfully raised a total of $6.36M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $30.08 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Debt – Conventional — $30.1M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Debt – Conventional - AMW Pharmaceuticals | Valuation |
investors |
|
| Nov, 2017 | Amount | Debt – Conventional - AMW Pharmaceuticals | Valuation |
investors |
|
| Jul, 2016 | Amount | Series C - AMW Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AMW Pharmaceuticals
AMW Pharmaceuticals has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, Hybio Pharmaceutical and KfW. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Founded Year | Domain | Location | |
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AMW Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AMW Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amw Pharmaceuticals Comparisons
Competitors of AMW Pharmaceuticals
AMW Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amw Pharmaceuticals
Frequently Asked Questions about AMW Pharmaceuticals
When was AMW Pharmaceuticals founded?
AMW Pharmaceuticals was founded in 2008 and raised its 1st funding round 6 years after it was founded.
Where is AMW Pharmaceuticals located?
AMW Pharmaceuticals is headquartered in Warngau, Germany. It is registered at Warngau, Bavaria, Germany.
Who is the current CEO of AMW Pharmaceuticals?
Friedrich Tegel is the current CEO of AMW Pharmaceuticals.
Is AMW Pharmaceuticals a funded company?
AMW Pharmaceuticals is a funded company, having raised a total of $6.36M across 4 funding rounds to date. The company's 1st funding round was a Series C of $6.36M, raised on Aug 26, 2014.
How many employees does AMW Pharmaceuticals have?
As of Dec 31, 2021, the latest employee count at AMW Pharmaceuticals is 78.
What does AMW Pharmaceuticals do?
AMW Pharmaceuticals, based in Germany, is focused on providing innovative drug delivery systems using biodegradable technologies. The company is involved in the pharmaceutical sector, offering solutions like Goserelin and Leuprorelin implants for hormone-sensitive tumor treatments. Their services include contract development and manufacturing, supporting global pharma and biotech partners. Advanced production facilities are utilized to cover the entire pharmaceutical value chain, ensuring cost-efficient therapies and improved patient adherence.
Who are the top competitors of AMW Pharmaceuticals?
AMW Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does AMW Pharmaceuticals offer?
AMW Pharmaceuticals offers Goserelin Implant, Leuprorelin Implant, and Drug Delivery Systems.
Who are AMW Pharmaceuticals's investors?
AMW Pharmaceuticals has 9 investors. Key investors include European Investment Bank, Hybio Pharmaceutical, KfW, Bayern Kapital, and SHS Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.